On the Verge of Full FDA Approval, New Details About Leqembi Death | Being Patient
On the Verge of Full FDA Approval, New Details About Leqembi Death | Being Patient
Three months before FDA is expected to make the final call on whether issue full approval status to Alzheimer's anti-amyloid Leqembi, new concerns arise about the drug's safety.
On the Verge of Full FDA Approval, New Details About Leqembi Death | Being Patient
Three months before FDA is expected to make the final call on whether issue full approval status to Alzheimer's anti-amyloid Leqembi, new concerns arise about the drug's safety.